華北制藥:頭孢呋辛酯片通過仿制藥一致性評價
中證網訊(記(ji)者 潘宇靜(jing))12月(yue)11日(ri)晚間,華北(bei)制(zhi)藥(yao)(600812)公(gong)(gong)告,公(gong)(gong)司(si)全資子(zi)公(gong)(gong)司(si)華民公(gong)(gong)司(si)收到國家藥(yao)監局核準簽(qian)發頭孢呋辛(xin)酯片(0.125g)的《藥(yao)品(pin)補(bu)充申請批件》,該藥(yao)品(pin)通(tong)過仿制(zhi)藥(yao)質量和(he)療效(xiao)一致性評價。